Publications by C3PA staff
(Priston, Rigby-Jones)
1. Soehle M, Wolf CF, Priston MJ, Neuloh G, Bien CG, Hoeft A, Ellerkmann RK (2015). Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: A prospective observational study. European Journal of Anaesthesiology 32(8), 527-534.
2. Wileman S, De Peralta T, Hanks S, Priston M, Rigby-Jones A, Sneyd JR (2015). Plasticisers and Endocrine Disrupting Compounds in Paediatric Dental Patients. Proceedings of IADR, Boston, March 2015. Read it here.
3. Brown S, Daugherty M, Park L, Brittain J, Priston M, Rigby-Jones A., Sneyd JR (2014). Systemic concentrations of levobupivacaine administered by rectus sheath catheter. British Journal of Anaesthesia, 112:188P.
4. Rose RJ, Priston MJ, Rigby-Jones AE, Sneyd JR (2012). The effect of temperature on di(2-ethylhexyl) phthalate leaching from PVC infusion sets exposed to lipid emulsions. Anaesthesia May; 67(5):514-20.
5. Sneyd JR, Rigby-Jones AE, Cross M, Tominaga H, Shimizu S, Ohkura T, Grimsehl K (2012). First human administration of MR04A3: a novel water-soluble nonbenzodiazepine sedative. Anesthesiology 2(116):385-395.
6. Rigby-Jones AE and Sneyd JR (2012). Pharmacokinetics and pharmacodynamics – is there anything new? Anaesthesia 76(1):5-11.
7. Rigby-Jones AE, Sneyd JR (2011). Propofol and children – what we know and what we do not know. Pediatric Anesthesia 21(3): 247–254.
8. Rigby-Jones AE and Sneyd JR (2010). New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth 105(3): 246-254.
9. Rigby-Jones AE, Sneyd JR, Vijn P, Boen P, Cross M (2010). First administration to man of Org 25435, an new intravenous anaesthetic: A Phase 1 Clinical Trial. BMC Anesthesiology 10:10.
10. Ravenelle F, Vachon P, Rigby-Jones AE, Sneyd JR, Le Garrec D, Gori S, Lessard D & Smith DC (2008). Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation.
Br J Anaesth 101(2):186-193.
11. Rigby-Jones A & Sneyd JR (2008). Cardiovascular changes after achieving constant effect site concentration of propofol. Anaesthesia 63(7):780.
12. Sneyd JR & Rigby-Jones AE (2007). Effect site: who needs it? Br J Anaesth 98(6):701-704.
13. Rigby-Jones AE, Priston MJ, Sneyd JR, McCabe AP, Davis GI, Tooley MA, Thorne GC, Wolf AR (2007). Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. Br J Anaesth 99(2):252-261.
14. McCabe A, Rigby-Jones AE, Priston MJ, Thorne GC, Sneyd JR, Wolf AR (2006). Remifentanil infusions for sedation in PICU: Correlation of infusion rate, whole blood concentration and Comfort Score. Pediatric Critical Care Medicine 7(4):411.
15. Ingram WM, Priston MJ, Sewell GJ (2006). Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson’s disease. Chromatogr B Analyt Technol Biomed Life Sci. 831(1-2):1-7.
16. Rigby-Jones AE, Priston MJ, Sneyd JR , Wolf AR. Pharmacokinetics of remifentanil sedation in paediatric intensive care. Eur J Anaesthesiol 2006; 23 (S37): 171.
17. Priston MJ, Grant IC, Hughes JM and Marquis PT (2005). Pilot study on potential degradation of drug efficacy resulting from Antarctic storage, transport and field conditions. Int J Circumpolar Health 64:2.
18. Priston MJ, Hughes JM, Santillo M, Christie IW. Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine. Anaesthesia 59 (10):979-83 (2004).
19. Murray DM, Thorne GC, Rigby-Jones AE, Tonucci D, Grimes S, Tooley MA & Wolf AR (2004). Electroencephalograph variables, drug concentrations and sedation scores in children emerging from propofol infusion anaesthesia. Paediatric Anaesthesia 14(2): 143-151.
20. Sewell GJ, Rigby-Jones AE & Priston MJ (2003). Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 28(5): 349-353.
21. Rigby-Jones AE, Nolan JA, Priston MJ, Wright PM, Sneyd JR & Wolf AR (2002). Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 97(6): 1393-1400.
2. Wileman S, De Peralta T, Hanks S, Priston M, Rigby-Jones A, Sneyd JR (2015). Plasticisers and Endocrine Disrupting Compounds in Paediatric Dental Patients. Proceedings of IADR, Boston, March 2015. Read it here.
3. Brown S, Daugherty M, Park L, Brittain J, Priston M, Rigby-Jones A., Sneyd JR (2014). Systemic concentrations of levobupivacaine administered by rectus sheath catheter. British Journal of Anaesthesia, 112:188P.
4. Rose RJ, Priston MJ, Rigby-Jones AE, Sneyd JR (2012). The effect of temperature on di(2-ethylhexyl) phthalate leaching from PVC infusion sets exposed to lipid emulsions. Anaesthesia May; 67(5):514-20.
5. Sneyd JR, Rigby-Jones AE, Cross M, Tominaga H, Shimizu S, Ohkura T, Grimsehl K (2012). First human administration of MR04A3: a novel water-soluble nonbenzodiazepine sedative. Anesthesiology 2(116):385-395.
6. Rigby-Jones AE and Sneyd JR (2012). Pharmacokinetics and pharmacodynamics – is there anything new? Anaesthesia 76(1):5-11.
7. Rigby-Jones AE, Sneyd JR (2011). Propofol and children – what we know and what we do not know. Pediatric Anesthesia 21(3): 247–254.
8. Rigby-Jones AE and Sneyd JR (2010). New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth 105(3): 246-254.
9. Rigby-Jones AE, Sneyd JR, Vijn P, Boen P, Cross M (2010). First administration to man of Org 25435, an new intravenous anaesthetic: A Phase 1 Clinical Trial. BMC Anesthesiology 10:10.
10. Ravenelle F, Vachon P, Rigby-Jones AE, Sneyd JR, Le Garrec D, Gori S, Lessard D & Smith DC (2008). Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation.
Br J Anaesth 101(2):186-193.
11. Rigby-Jones A & Sneyd JR (2008). Cardiovascular changes after achieving constant effect site concentration of propofol. Anaesthesia 63(7):780.
12. Sneyd JR & Rigby-Jones AE (2007). Effect site: who needs it? Br J Anaesth 98(6):701-704.
13. Rigby-Jones AE, Priston MJ, Sneyd JR, McCabe AP, Davis GI, Tooley MA, Thorne GC, Wolf AR (2007). Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. Br J Anaesth 99(2):252-261.
14. McCabe A, Rigby-Jones AE, Priston MJ, Thorne GC, Sneyd JR, Wolf AR (2006). Remifentanil infusions for sedation in PICU: Correlation of infusion rate, whole blood concentration and Comfort Score. Pediatric Critical Care Medicine 7(4):411.
15. Ingram WM, Priston MJ, Sewell GJ (2006). Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson’s disease. Chromatogr B Analyt Technol Biomed Life Sci. 831(1-2):1-7.
16. Rigby-Jones AE, Priston MJ, Sneyd JR , Wolf AR. Pharmacokinetics of remifentanil sedation in paediatric intensive care. Eur J Anaesthesiol 2006; 23 (S37): 171.
17. Priston MJ, Grant IC, Hughes JM and Marquis PT (2005). Pilot study on potential degradation of drug efficacy resulting from Antarctic storage, transport and field conditions. Int J Circumpolar Health 64:2.
18. Priston MJ, Hughes JM, Santillo M, Christie IW. Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine. Anaesthesia 59 (10):979-83 (2004).
19. Murray DM, Thorne GC, Rigby-Jones AE, Tonucci D, Grimes S, Tooley MA & Wolf AR (2004). Electroencephalograph variables, drug concentrations and sedation scores in children emerging from propofol infusion anaesthesia. Paediatric Anaesthesia 14(2): 143-151.
20. Sewell GJ, Rigby-Jones AE & Priston MJ (2003). Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 28(5): 349-353.
21. Rigby-Jones AE, Nolan JA, Priston MJ, Wright PM, Sneyd JR & Wolf AR (2002). Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 97(6): 1393-1400.